Law channel feed – Endpoints News

Law channel feed

Supreme Court tosses Bristol Myers' bid to revive $1.2B CAR-T case against Gilead

3 years ago

SCOTUS to review Amgen-Sanofi patent battle as a proxy for how narrowly pharma patents will need to be written

3 years ago

Teva reaches $523M agreement with New York in latest opioid-related settlement

3 years ago

With drug price negotiations in the books, Dems turn to launch prices as the next challenge

3 years ago

CVS, Walgreens and Walmart reach nearly $12B settlement over opioid epidemic

3 years ago

For months Biden has touted his win over pharma in the election lead-up. Will it help?

3 years ago

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

3 years ago

Gilead finds 'critical holes' in the government's HIV patent case against it

3 years ago

In next step of opioid saga, McKinsey reaches proposed agreement with school districts and local governments

3 years ago

Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations?

3 years ago

Viatris and others become latest targets of Novartis' Entresto patent litigation

3 years ago

Ex-Genentech scientist sentenced to six months in prison for stealing trade secrets

3 years ago

Will feds reclassify 'magic mushroom' therapies? Seattle doctor ramps up court battle

3 years ago

Takeda sues Apotex over prospective generic versions of its top leukemia drug

3 years ago

Clinical trial coordinators sentenced to prison after data falsification scheme

3 years ago

Big Pharma PACs blanket the election field with millions in contributions ahead of midterms

3 years ago

Investors who lost money from Neil Woodford's fund file lawsuit against investment platform

3 years ago

Senators call on NIH to take action on slow-to-report clinical trial sponsors

3 years ago

Pfizer petitions Supreme Court over anti-kickback case, says prior opinions could 'cut off charitable or family aid'

3 years ago

Supreme Court rejects Novartis' request for stay in Gilenya patent battle

3 years ago

Advocacy group and former antitrust official look to comment on Illumina's controversial Grail merger

3 years ago

Eli Lilly and Teva prepare for court battle over migraine med rivalry

3 years ago

After coverage restrictions for Alzheimer's drugs, bipartisan House bill would force CMS to review drugs individually

3 years ago

New inflation-linked drug rebates go into effect on Saturday

3 years ago

First page Previous page 26 27 282930 31 32 Next page Last page